Ibutamoren mesylate by Lumos Pharma for Growth Hormone Deficiency: Likelihood of Approval
Ibutamoren mesylate is under clinical development by Lumos Pharma and currently in Phase II for Growth Hormone Deficiency.
Ibutamoren mesylate is under clinical development by Lumos Pharma and currently in Phase II for Growth Hormone Deficiency.
What's Your Reaction?
